Here we go again. The latest settlement in the parade was made by the Alpharma subsidiary of King Pharmaceuticals, as reported by Reuters :
Alpharma Inc, a unit of King Pharmaceuticals (KG.N), has agreed to pay $42.5 million to resolve allegations that it gave kickbacks to doctors to prescribe the pain drug Kadian and misrepresented its safety and effectiveness , the Justice Department said on Tuesday.
Kadian, which is based on morphine [that is, a long-acting...
Post new comment